Learn about the latest advances in dietary interventions and metabolism. Dr. Charles Edelstein, MD will speak about the impacts of raising serum uric acid with a uricase inhibitor and its impact on progression in PKD rat and mouse models. Next, Dr. Cortney Steele, PhD discusses her work using machine learning on images from the TEMPO 3:4 clinical trial to determine the association of visceral fat with change in TKV.
- Күн бұрын
Dietary Interventions and Metabolism for Polycystic Kidney Disease | Part II
- Рет қаралды 64
Пікірлер